pharma · Non Hodgkin Lymphoma
Xynomic Pharmaceuticals
Xynomic Pharmaceuticals is a pharma organization headquartered in CN. Primary therapeutic focus areas include Non Hodgkin Lymphoma. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Abexinostat
Phase 2 · small molecule · Non Hodgkin Lymphoma
Abexinostat for Non Hodgkin Lymphoma is a Phase 2 program (small_molecule) at Xynomic Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code XYN-609
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Xynomic Pharmaceuticals
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Non Hodgkin Lymphoma
- Status
- active
- Trials
- 1